ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is a subtype of breast cancer that is deficient in protein expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2); constituting approximately 15–20% of breast cancers [2, 3].